OpenVSafe by OpenVAERS
Search V-safe

AHV-21883-63307

2 vaccinations 6 coded responses 15 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
480 / MI
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-11
    Registered in v-safe
  3. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-11
    Survey response — day 0, dose 2
    MedDRA: Heart rate increased — Feeling: Good · Headache
    Free text: Elevated heart rate
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia, Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness
    Free text: Swollen lymph nodes, numbness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Numbness on left side of body
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-01-18
    Survey response — day 7, dose 2
    MedDRA: Dizziness — Feeling: Fair · Headache
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-25
    Survey response — day 14, dose 2
    MedDRA: Hypogeusia — Feeling: Fair
    Free text: Diminished sense of taste that has been present since second dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-09
  18. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Breakthrough COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Breakthrough Covid in September
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-01-11
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  22. 2022-01-12

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — day 0, dose 2

2021-01-11

Systemic reaction (other): Elevated heart rate

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Swollen lymph nodes, numbness

2021-01-14

Systemic reaction (other): Numbness on left side of body

Release 2 — day 7, dose 2

2021-01-18

Systemic reaction (other): Dizziness

Release 2 — day 14, dose 2

2021-01-25

Symptoms: Diminished sense of taste that has been present since second dose

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Breakthrough Covid in September

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreakthrough COVID-19 · · ✓
SDHypogeusia ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release